Alison Conlin
Overview
Explore the profile of Alison Conlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Loh K, Duberstein P, Zittel J, Lei L, Culakova E, Xu H, et al.
J Geriatr Oncol
. 2020 Jan;
11(6):1006-1010.
PMID: 31899198
Objectives: Older self-perceived age is associated with poor health and higher healthcare utilization in the geriatric population. We evaluated the associations of self-perceived age with geriatric assessment (GA) domain impairments...
12.
Loh K, Kleckner I, Lin P, Mohile S, Canin B, Flannery M, et al.
J Am Geriatr Soc
. 2019 Apr;
67(5):1005-1011.
PMID: 31034591
Background/objective: Exercise interventions improve anxiety and mood disturbances in patients with cancer. However, studies are limited in older adults with cancer. We assessed the effects of exercise on anxiety, mood,...
13.
Loh K, Mohile S, Lund J, Epstein R, Lei L, Culakova E, et al.
Oncologist
. 2019 Apr;
24(6):e292-e302.
PMID: 31015317
Background: Ensuring older patients with advanced cancer and their oncologists have similar beliefs about curability is important. We investigated discordance in beliefs about curability in patient-oncologist and caregiver-oncologist dyads. Materials...
14.
Kleckner I, Kamen C, Cole C, Fung C, Heckler C, Guido J, et al.
Support Care Cancer
. 2019 Apr;
27(12):4615-4625.
PMID: 30937600
Purpose: A growing body of research suggests that inflammation plays a role in many chemotherapy-related toxicities such as fatigue, anxiety, and neuropathy. Regular exercise can change levels of individual cytokines...
15.
Loh K, Mohile S, Epstein R, McHugh C, Flannery M, Culakova E, et al.
Cancer
. 2019 Mar;
125(14):2506-2513.
PMID: 30920646
Background: Older patients with advanced cancer who are 100% certain they will be cured pose unique challenges for clinical decision making, but to the authors' knowledge, the prevalence and correlates...
16.
Borges V, Ferrario C, Aucoin N, Falkson C, Khan Q, Krop I, et al.
JAMA Oncol
. 2018 Jun;
4(9):1214-1220.
PMID: 29955792
Importance: Treatment options for patients with disease progression after treatment with trastuzumab, pertuzumab, and ado-trastuzumab emtansine (T-DM1) are limited. Tucatinib is an oral, potent, human epidermal growth factor receptor 2...
17.
Murthy R, Borges V, Conlin A, Chaves J, Chamberlain M, Gray T, et al.
Lancet Oncol
. 2018 May;
19(7):880-888.
PMID: 29804905
Background: Tucatinib is a potent and selective oral HER2 tyrosine kinase inhibitor, with the potential to provide a well tolerated new treatment option for patients whose disease has progressed on...
18.
Peereboom D, Murphy C, Ahluwalia M, Conlin A, Eichler A, Van Poznak C, et al.
Neuro Oncol
. 2014 Jan;
16(4):579-83.
PMID: 24470546
Background: For patients with progressive breast cancer brain metastasis (BCBM) after whole brain radiotherapy (WBRT), few options exist. Patupilone is an epothilone that crosses the blood-brain barrier. We hypothesized that...
19.
Morris P, Fazio M, Farooki A, Estilo C, Mallam D, Conlin A, et al.
J Oral Maxillofac Surg
. 2012 Feb;
70(12):2768-75.
PMID: 22330331
Purpose: Oversuppression of bone turnover can be a critical factor in the pathogenesis of osteonecrosis of the jaw (ONJ). We investigated N-telopeptide of type I collagen (NTX) and bone-specific alkaline...